MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell lymphomas, and highly recurrent and specific rearrangements have defined distinct molecular subtypes linked to unique clinicopathological features(1,2). In contrast, several well-characterized lymphoma entitie...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Steidl, Christian, Shah, Sohrab P., Woolcock, Bruce W., Rui, Lixin, Kawahara, Masahiro, Farinha, Pedro, Johnson, Nathalie A., Zhao, Yongjun, Telenius, Adele, Ben Neriah, Susana, McPherson, Andrew, Meissner, Barbara, Okoye, Ujunwa C., Diepstra, Arjan, van den Berg, Anke, Sun, Mark, Leung, Gillian, Jones, Steven J., Connors, Joseph M., Huntsman, David G., Savage, Kerry J., Rimsza, Lisa M., Horsman, Douglas E., Staudt, Louis M., Steidl, Ulrich, Marra, Marco A., Gascoyne, Randy D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902849/
https://ncbi.nlm.nih.gov/pubmed/21368758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature09754
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia